John Hironimus, CEO, Origami Surgical

This week, we revisit our conversation with John Hironimus, CEO of Origami Surgical and a seasoned medical device executive known for bringing breakthrough technologies to market. Over 25 years, John has helped scale innovations that improve care for patients, clinicians, and providers—always with an entrepreneur's instinct and a commitment to building world-class teams. John began his career at United States Surgical Corporation, supporting surgeons as they adopted advanced procedures. He later built the domestic and international commercial engine for Salient Surgical Technologies, driving growth from $40M to more than $350M and ultimately leading to the company's acquisition by Medtronic in 2011. Since then, he has led commercial organizations at Outset Medical and Dilon Technologies, continuing to champion technologies that elevate clinical outcomes. Today, as CEO of Origami Surgical, John is focused on scaling novel surgical solutions and shaping the future of minimally invasive care. He is a graduate of Indiana University, where he earned a degree in Public Financial Management.